Avacta Group PLC
LSE:AVCT
Avacta Group PLC
LSE:AVCT
Price:
44 GBX
7.32%
Market Closed
Updated:
May 23, 2024
Avacta Group PLC
Additional Paid In Capital
|
Avacta Group PLC
Additional Paid In Capital Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Avacta Group PLC
LSE:AVCT
|
Additional Paid In Capital
£75.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
150%
|
CAGR 10-Years
13%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Additional Paid In Capital
$987.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Additional Paid In Capital
$1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Additional Paid In Capital
$894.6m
|
CAGR 3-Years
42%
|
CAGR 5-Years
236%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Additional Paid In Capital
£1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Additional Paid In Capital
£179.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
See Also
What is Avacta Group PLC's Additional Paid In Capital?
Additional Paid In Capital
75.7m
GBP
75.7m
GBP
Based on the financial report for Jun 30, 2023, Avacta Group PLC's Additional Paid In Capital amounts to 75.7m GBP.
What is Avacta Group PLC's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
13%
13%
Over the last year, the Additional Paid In Capital growth was 38%. The average annual Additional Paid In Capital growth rates for Avacta Group PLC have been 12% over the past three years , 150% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
